Clinical Trial Update: LAG3 PET Imaging in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating a LAG-3–targeted PET imaging tracer in metastatic solid tumors; the trial is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• LAG-3 PET imaging tracer

Snippet

Sponsor: University Medical Center Groningen | Conditions: Metastatic Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING